Abnormal vaginal bleeding in adolescence as the presenting symptom of a bleeding diathesis

Journal of Pediatric and Adolescent Gynecology

Volumn 12, Issue 3, 1999, Pages 127-131

  Ellis, M H ^a   Beyth, Y ^b,c  

^a Division of Transfusion Medicine   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

Bleeding diathesis; Bleeding disorders; Menorrhagia; Vaginal bleeding, abnormal

Indexed keywords

BLOOD CLOTTING FACTOR; DESMOPRESSIN; ESTROGEN; FIBRINOGEN; PROTHROMBIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ASSAY; BLEEDING TENDENCY; BLEEDING TIME; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING PARAMETERS; FAMILY HISTORY; FIBRINOGEN BLOOD LEVEL; GLANZMANN DISEASE; HEMOSTASIS; HUMAN; MENORRHAGIA; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SCREENING; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; VAGINA BLEEDING; VON WILLEBRAND DISEASE;

EID: 0033172466     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1038-3188(99)00004-2     Document Type: Short Survey

References (39)

1. Janssen CA, Scholten PC, Heintz AP: Reconsidering menorrhagia in gynecological practice: Is a 30-year-old definition still valid? Eur J Obstet Gynecol Reprod Biol 1998; 78:69
2. Rees M. Menorrhagia: BMJ 1987; 294:759
3. Coller BS, Beer JH, Scudder LE, Steinberg MH: Collagen-platelet interactions: Evidence for a direct interaction of collagen with platelet GP Ia/IIa and an indirect interaction with GP IIb-IIIa mediated by adhesive proteins. Blood 1989; 72:182
4. Fauvel F, Grant MC, Legrand Y, et al: Interaction of blood platelets with microfibrillar extract from adult bovine aorta: Requirement for von Willebrand factor. Proc Natl Acad Sci USA 1983; 80:551
5. Born GV: Platelets: Functional physiology. In: Biggs R (ed): Human Blood Coagulation: Hemostasis and Thrombosis. London, Blackwell, 1972, p 159
6. Colman RW, Marder VJ, Salzman EW, Hirsh J: Overview of hemostasis. In: Hirsh J, Marder V, Salzman E and Colman R (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice, (3rd Ed.). Philadelphia, JB Lippincott, 1993, p 6
7. Miletich JP, Jackson CM, Majerus PW: Properties of the factor X-binding site on human platelets. J Biol Chem 1978; 253:6908
8. Rapaport SI: Fibrinolysis. In: Rapaport SI (ed): Introduction to Hematology, (2nd Ed.). Philadelphia, JB Lippincott, 1987, pp 44-49
9. Rodeghiero F, Castaman G, Dini E: Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69:454
10. Nichols WC, Ginsburg D: Von Willebrand disease. Medicine 1997; 76:1
11. Sadler JE: A revised classification of von Willebrand disease. Thromb Hemost 1994; 71:520
12. Holmberg L, Nilsson IM: Von Willebrand's disease. Eur J Haematol 1992; 48:127
13. Von Willebrand EA: Hereditar pseudohemofili. Fin Laekaresaellsk Hand 1926; 68:87
14. Zhang ZP, Blamback M, Nyman D, Anvret M: Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland islands. Proc Natl Acad Sci USA 1993; 90:7937
15. Asakai R, Chung DW, Davie EW, Seligsohn U: Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325:153
16. Berliner S, Horowitz I, Martinoxitz U, et al: Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coag Fibr 1992; 3:465
17. Bray PF: Inherited diseases of platelet glycoproteins: Considerations for rapid molecular characterization. Thromb Hemost 1994; 72:492
18. Markovitch O, Ellis M, Holzinger M, et al: Severe juvenile vaginal bleeding due to Glanzmann's thrombasthenia: Case report and review of the literature. Am J Hematol 1998; 57:225
19. Edlund M, Blamback M, von-Schoultz B, Andersson O: On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53:234
20. Kadir RA, Economides DL, Sabin CA, et al: Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351:485
21. Claessens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol 1981; 139:277
22. Falcone T, Desjardines C, Bourque J, et al: Dysfunctional uterine bleeding in adolescents. J Reprod Med 1994; 39:761
23. Cartwright IJ, Hampton KK, Macneil S, et al: A hemorrhagic platelet disorder associated with altered stimulus-response coupling and abnormal membrane phospholipid composition. Br J Haematol 1994; 88:129
24. Peyvandi F, Tuddenham EG, Akhtari AM, et al: Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII. Br J Hematol 1998; 100:773
25. Peyvandi F, Mannucci PM, Lak M, et al: Congenital factor X deficiency: Spectrum of bleeding symptoms in 32 Iranian patients. Br J Hematol 1998; 102:626
26. Bennett K, Daley ML, Pike C: Factor V deficiency and menstruation: A gynecologic challenge. Obstet Gynecol 1997; 89:839
27. Smith YR, Quint EH, Hertzberg RB: Menorrhagia in adolescents requiring hospitalization. J Ped Adolesc Gynecol 1998; 11:13
28. Leslie SD, Toy PTCY: Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 1991; 96:770
29. Romer T: Benefit of GnRH analogue pretreatment for hysteroscopic surgery in patients with bleeding disorders. Gynecol Obstet Invest 1998; 45:12
30. Shpilberg O, Blumenthal R, Sofer O, et al: A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. Leuk Lymphoma 1995; 19:141
31. Berliner S, Horowitz I, Martinowitz U, et al: Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coag Fibrinolysis 1992; 3:465
32. Bonnar J, Sheppard BL: Treatment of menorrhagia during menstruation: Randomized controlled trial of ethamsylate, mefenamic acid and tranexamic acid. Brit Med J 1996; 313:579
33. Greer IA, Lowe GD, Walker JJ, Forbes CD: Hemorrhagic problems in obstetrics and gynecology in patients with congenital coagulopathies. Br J Obstet Gynecol 1991; 98:909
34. Mannucci PM: Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years. Blood 1997; 90: 2515
35. Rose EH, Aledort LM: Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann Int Med 1991; 114:563
36. Scott JP, Montgomery RR. Therapy of von Willebrand disease. Sem Thomb Hemost 1993; 19:37
37. Anonymous: Practice parameter for the use of fresh-frozen plasma, cryoprecipitate and platelets. JAMA 1994; 271:777
38. Klein HG, Dodd RY, Dzik WH, et al: Current status of solvent/detergent-treated frozen plasma. Transfusion 1998; 38:102
39. Brown CH III, Weisberg RJ, Natelson EA et al: Glanzmann's thrombasthenia: Assessment of response to platelet transfusions. Transfusion 1975; 15:124